-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Press Release: Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development
Press Release: Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development
Press Release: Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development
Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development
SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company"), announces the appointment of David Racz as Senior Vice President of Global Sales and Business Development.
Mr. David Racz has held global, senior level positions with distinguished pharmaceutical companies including Pfizer, GlaxoSmithKline, and Novartis. He began his pharmaceutical career at Pfizer Pharmaceuticals where he became vice president of sales and human resources and managed the largest expansion in Pfizer's sales force in history.
Shortly thereafter, SmithKline Beecham recruited David to manage over 4,000 employees in 20 countries throughout Asia, Latin America, Australia, and South Africa in sales, marketing, and research and development. He was also a key member of the team responsible for orchestrating the unparalleled transcontinental merger of SmithKline and Beecham.
In 2002, David was recruited by Novartis Pharmaceuticals as senior vice president North America. In this capacity, he delivered strategy and resource allocation for an $8 billion health care company and oversaw 14,000 global employees in pharmaceutical operations, global oncology, manufacturing and R&D.
Further, David was Senior Vice President for Mona Vie Inc. ("Mona Vie"), the fastest-growing private company in the food and beverage industry. With annual sales in excess of $942 million, David facilitated growth exceeding 100% per quarter, year over year, while in this role.
Over the past 10 years David has amassed a wealth of knowledge and experience in the cannabis industry. He began his cannabis career in 2008, in Colorado where he worked with legislative bodies to develop the then emerging medical cannabis laws.
In 2011 working under multiple controlled substance license(s) issued from The Canadian Department of Health, David led a team that was responsible for:
-- Acquisition and/or application of 6 cannabinoid related patents -- Discovery of 2 previously unidentified cannabis chemical structures -- Amassed a cannabis DNA library of over 4000 strains -- Early advancement of cannabis genetic engineering for application in large scale production.
He has served as a U.S. Army medical service corps officer, achieving the rank of major, and was awarded numerous times for service and merit. David earned his bachelor's degree from Wayne State University and his master's degree from Troy University.
About Green Hygienics Holdings Inc.
Green Hygienic Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The Company's corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.
Hygienics is the science of preserving and promoting the health of individuals, communities, and the planet.
For further information about Green Hygienics Holdings Inc., please visit the Company's website at: http://www.greenhygienics.com/
Follow us on Facebook, Twitter, Instagram and Linkedin
Corporate Communications:
Heidi Thomasen
IR@GreenHygienics.com
Toll Free 1.855.802.0299
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
This document contains forward-looking statements. In evaluating these forward-looking statements, you should consider various factors, including our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.
Public Relations:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
(END) Dow Jones Newswires
July 27, 2021 08:34 ET (12:34 GMT)
Press Release: Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development
新闻稿:Green Hygienics Holdings Inc.(GRYN)任命David racz为负责全球销售和业务发展的高级副总裁
Green Hygienics Holdings Inc. (GRYN) Appoints David Racz as Senior Vice President of Global Sales and Business Development
绿色卫生控股公司(GRYN)任命大卫·拉茨为负责全球销售和业务发展的高级副总裁
SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company"), announces the appointment of David Racz as Senior Vice President of Global Sales and Business Development.
圣迭戈,2021年7月27日(环球网)--通过InvestorWire--Green Hygienics Holdings Inc.(场外交易市场代码:GRYN)(以下简称“Green Hygienics”或“公司”)宣布任命大卫·拉茨为负责全球销售和业务发展的高级副总裁。
Mr. David Racz has held global, senior level positions with distinguished pharmaceutical companies including Pfizer, GlaxoSmithKline, and Novartis. He began his pharmaceutical career at Pfizer Pharmaceuticals where he became vice president of sales and human resources and managed the largest expansion in Pfizer's sales force in history.
David racz先生曾在辉瑞、葛兰素史克和诺华等知名制药公司担任全球高级职位。他在辉瑞制药公司(Pfizer PharmPharmticals)开始了他的制药生涯,在那里他成为负责销售和人力资源的副总裁,并管理着辉瑞历史上最大规模的销售队伍扩张。
Shortly thereafter, SmithKline Beecham recruited David to manage over 4,000 employees in 20 countries throughout Asia, Latin America, Australia, and South Africa in sales, marketing, and research and development. He was also a key member of the team responsible for orchestrating the unparalleled transcontinental merger of SmithKline and Beecham.
此后不久,SmithKline Beecham招聘了David,在亚洲、拉丁美洲、澳大利亚和南非的20个国家和地区管理4000多名员工,从事销售、营销和研发工作。他也是负责策划史无前例的史密斯克莱恩(SmithKline)和比彻姆(Beecham)跨洲合并的团队的关键成员。
In 2002, David was recruited by Novartis Pharmaceuticals as senior vice president North America. In this capacity, he delivered strategy and resource allocation for an $8 billion health care company and oversaw 14,000 global employees in pharmaceutical operations, global oncology, manufacturing and R&D.
2002年,大卫被诺华制药公司聘为北美高级副总裁。在这一职位上,他为一家价值80亿美元的医疗保健公司提供战略和资源分配,并监督制药业务、全球肿瘤学、制造和研发领域的1.4万名全球员工。
Further, David was Senior Vice President for Mona Vie Inc. ("Mona Vie"), the fastest-growing private company in the food and beverage industry. With annual sales in excess of $942 million, David facilitated growth exceeding 100% per quarter, year over year, while in this role.
此外,大卫是Mona Vie Inc.(“Mona Vie”)的高级副总裁,Mona Vie是食品和饮料行业增长最快的私营公司。大卫在担任这一职务期间,年销售额超过9.42亿美元,推动了每季度超过100%的同比增长。
Over the past 10 years David has amassed a wealth of knowledge and experience in the cannabis industry. He began his cannabis career in 2008, in Colorado where he worked with legislative bodies to develop the then emerging medical cannabis laws.
在过去的10年里,大卫积累了丰富的大麻行业知识和经验。他于2008年在科罗拉多州开始了他的大麻职业生涯,在那里他与立法机构合作,制定了当时新兴的医用大麻法律。
In 2011 working under multiple controlled substance license(s) issued from The Canadian Department of Health, David led a team that was responsible for:
2011年,大卫根据加拿大卫生部颁发的多种受控物质许可证开展工作,他领导的团队负责:
-- Acquisition and/or application of 6 cannabinoid related patents -- Discovery of 2 previously unidentified cannabis chemical structures -- Amassed a cannabis DNA library of over 4000 strains -- Early advancement of cannabis genetic engineering for application in large scale production.
--获得和/或应用6项与大麻素相关的专利--发现2种以前未被识别的大麻化学结构--积累了4000多种大麻DNA文库--大麻基因工程的早期进展,用于大规模生产。
He has served as a U.S. Army medical service corps officer, achieving the rank of major, and was awarded numerous times for service and merit. David earned his bachelor's degree from Wayne State University and his master's degree from Troy University.
他曾担任美国陆军医疗服务队军官,获得少校军衔,并多次因服务和功绩而被授予荣誉。大卫在韦恩州立大学获得学士学位,在特洛伊大学获得硕士学位。
About Green Hygienics Holdings Inc.
关于Green Hygienics Holdings Inc.
Green Hygienic Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The Company's corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.
绿色卫生控股公司(场外交易市场代码:GRYN)(以下简称“Green Hygienics”或“公司”)是一家总部设在加利福尼亚州的创新、技术驱动型企业,专注于工业大麻的高标准种植和加工,以及制药级生物活性大麻的制造。该公司的公司使命是坚持最高的运营标准,始终如一地向消费者提供安全和优质的产品,并与CPG(消费品)和制药公司建立合作伙伴关系。
Hygienics is the science of preserving and promoting the health of individuals, communities, and the planet.
卫生学是保护和促进个人、社区和地球健康的科学。
For further information about Green Hygienics Holdings Inc., please visit the Company's website at: http://www.greenhygienics.com/
欲了解有关绿色卫生控股公司的更多信息,请访问公司网站:http://www.greenhygienics.com/。
Follow us on Facebook, Twitter, Instagram and Linkedin
在Facebook、Twitter、Instagram和LinkedIn上关注我们
Corporate Communications:
企业通信:
Heidi Thomasen
海蒂·托马森
IR@GreenHygienics.com
邮箱:ir@GreenHygienics.com
Toll Free 1.855.802.0299
免费电话1.855.802.0299
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
关于前瞻性陈述的警告性声明
This document contains forward-looking statements. In evaluating these forward-looking statements, you should consider various factors, including our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.
本文档包含前瞻性陈述。在评估这些前瞻性陈述时,您应该考虑各种因素,包括我们改变公司方向的能力;我们跟上新技术和不断变化的市场需求的能力;以及我们业务的竞争环境。这些因素和其他因素可能导致我们的实际结果与任何前瞻性陈述大不相同。
Public Relations:
公共关系:
InvestorBrandNetwork (IBN)
投资者品牌网络(IBN)
Los Angeles, California
加利福尼亚州洛杉矶
www.InvestorBrandNetwork.com
Www.InvestorBrandNetwork.com
310.299.1717 Office
310.299.1717办事处
Editor@InvestorBrandNetwork.com
电子邮箱:Editor@InvestorBrandNetwork.com
(END) Dow Jones Newswires
(完)道琼通讯社
July 27, 2021 08:34 ET (12:34 GMT)
2021年7月27日东部时间08:34(格林尼治标准时间12:34)
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧